(0.18%) 5 140.75 points
(0.18%) 38 509 points
(0.26%) 17 892 points
(-0.87%) $83.12
(1.98%) $1.961
(-0.06%) $2 345.90
(0.06%) $27.55
(0.63%) $927.90
(-0.23%) $0.933
(-0.25%) $11.00
(-0.30%) $0.798
(1.16%) $92.94
Live Chart Being Loaded With Signals
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality...
Stats | |
---|---|
Šios dienos apimtis | 27.33M |
Vidutinė apimtis | 1.04M |
Rinkos kapitalizacija | 30.27M |
EPS | £0 ( 2024-04-23 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | 3.00 |
ATR14 | £0.0720 (0.67%) |
Tūris Koreliacija
C4X Discovery Holdings Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
NVT.L | 0.95 |
MCL.L | 0.942 |
MAST.L | 0.942 |
ORCA.L | 0.939 |
ETX.L | 0.938 |
GRL.L | 0.936 |
MOTR.L | 0.933 |
CCZ.L | 0.931 |
AVO.L | 0.928 |
MIRI.L | 0.928 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
BILN.L | -0.946 |
JPSA.L | -0.924 |
JGSA.L | -0.917 |
MPO.L | -0.915 |
FEDF.L | -0.913 |
TFRN.L | -0.912 |
XFFE.L | -0.912 |
DEMR.L | -0.904 |
K3C.L | -0.901 |
MAFL.L | -0.894 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
C4X Discovery Holdings Koreliacija - Valiuta/Žaliavos
C4X Discovery Holdings Finansinės ataskaitos
Annual | 2023 |
Pajamos: | £1.71M |
Bruto pelnas: | £1.67M (97.78 %) |
EPS: | £-0.0442 |
FY | 2023 |
Pajamos: | £1.71M |
Bruto pelnas: | £1.67M (97.78 %) |
EPS: | £-0.0442 |
FY | 2022 |
Pajamos: | £2.70M |
Bruto pelnas: | £2.57M (95.18 %) |
EPS: | £-0.0357 |
FY | 2021 |
Pajamos: | £5.64M |
Bruto pelnas: | £5.55M (98.40 %) |
EPS: | £-0.0400 |
Financial Reports:
No articles found.
C4X Discovery Holdings
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality. The company's product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.